Skip to main content

Experts and Regulation

For all the global health coordination, and all the international research collaboration, there is no movement toward scope of practice, labor regulation, prescribing regulation or biotechnological responsibility standardization. 

We should encourage measured progress toward accountability in medicine regulation, and we should do so with countries at the table.  


  • What are the medical professions, credentials, approved education and scope of practice in healthcare, per country? What are the community healthcare worker (CHW) roles if allowed, per country? What would countries like to see adjusted or mirrored? 

  • Which procedures are allowed for each healthcare profession? What are the rationales, inclusive of supply and demand and access issues? 

  • What are the differences in approvals and guidelines for medicine safety, and for who can prescribe what? What is the healthcare political climate in various countries and how does this affect decision making? What analytics are available for expanded scopes? 

  • What are the rules for over the counter medication, by country? What is being debated within these countries at this time? 

  • What are the timelines, progress indicators and metrics for the basic comparison listing of healthcare professional regulations? One goal should be a detailed list and comparison of professional titles and scope, and countries should be asked if they share this goal. 

  • What are the timelines, progress indicators and metrics toward goals of listing and accounting for medicine regulation? One goal should be a detailed list and comparison of what medicines are available over the counter versus prescription versus classified as illegal, and countries should be asked if they share this goal. 

  • What is the evidence for current scope of practice for all healthcare professions? Ask the countries how important evidence-based scope of practice regulation is to them, in comparison to access, and what basics could be agreed upon.  

  • What is the estimated cost of time, money and other resources when global coordination is hindered by inconsistent medicine and labor rules? Ask these countries for first hand accounts of global coordination and  prescription as well as scope of practice barriers or lack of barriers.  

  • What are the audit and validation tools for healthcare education, by credential? Ask the countries. 

  • What is the planned data aggregation and research to better shape professional regulation in healthcare?  Ask the healthcare facility leadership, labor regulation leadership and professional leadership. 

  • What are the differences in health outcomes and in patient safety outcomes with various over the counter rules? Ask the countries how important these outcomes are to decisions, and ask them what initial data aggregation steps can be taken to achieve outcome evaluations. 

  • What is the strategic plan for health and safety outcome evaluations, by country, by prescribing rules? Ask these countries if they’d like to be part of a cool, new global strategic plan. 



For global health to boost credibility, some understanding and accounting for medicine’s professional allowance is necessary. The current lack of listing or comparison of professional scope of practice, and of prescribing regulation, suggests that the industry is even more varied than anticipated. Global health must account for international differences in medical scope of practice, and should do so with quality to the process.


Comments

Popular posts from this blog

Mortality Data Accuracy Aligns With Hope

Mortality data accuracy is a cornerstone of pandemic management, and it is a cornerstone of any health issue. COVID data inaccuracy offers tremendous opportunity to improve healthcare epidemiology sustainably. And we can improve only when welcomed into one another's national space and place.   Mortality accuracy is challenging due to statistical logistics and geopolitics; it is also challenging due to sociocultural considerations.  We don't really know how each affects accuracy of the mortality data . We don't know the weight of each consideration because we haven't properly assessed them.   We have addressed some solutions for statistical logistics with COVID, such as improving real time data, use of EHR, use of cemetery and cremation data, use of excess death or other metrics, consistency to death definitions and strengthened regional epidemiology.  We have addressed few solutions for geopolitics related to COVID. Most solutions rely on normalizing the ex...

Oxygen

Keeping it simple for oxygen coordination is best accomplished when we're welcomed in.  It’s good to support global leadership in medical oxygen supply management for underserved communities and countries in need.  It’s great to support efforts that strengthen individual country leadership toward national strategies on medical oxygen supply management.   Both require some tread into a country’s vulnerabilities on medical needs.  Let’s tread meaningfully and in a way that assures a welcome back.  Detail the coordinating agencies or government departments responsible for medical oxygen supply receipt. Meet with health administrators.  Detail a country’s current policies, compare with a global review and detail opportunities for policies on oxygen management. Is medical oxygen supply and/or maintenance an ongoing regulatory component within a country? What would it take to sharpen regulatory efforts? Is medical oxygen supply a component to ongoing emergen...

Doing It

  Building better for current and future pandemics seems reasonable, and doable.  Yet managing pandemics also seemed reasonable and doable during the decades of funded planning in the United States. Funding supported to thwart bioterrorism, by the way.  So the main lesson learned from these first years of a fresh pandemic should incorporate a way to circumvent false assurances and reliance on planners.  And how do we move on from planning? Doing.  If the World Health Organization recommends building better and getting sustainable development back on track , do so. Don’t continue to plan, just do. And do it with LMIC partnership in their place and space.  Let’s energize this doable move with COVID vaccine and therapeutics. When the vaccines, therapeutics and supplies are delivered to countries, particularly low and middle income (LMIC) countries, are they delivered to credentialed labor supply? How is the labor credentialing assured across borders? How is la...